Pelosi's pricing plan is out, and we've got questions

Nancy Pelosi finally unveiled her much-anticipated plan to lower drug prices, and it’s certainly thorough. If passed, the bill would allow the government to negotiate drug prices, create a price cap for drugs based on their cost in foreign countries, and force pharma to pay back price hikes above inflation.

But a lot’s still unclear, STAT’s Nicholas Florko and Lev Facher write — including whether legislators on either side of the aisle will go for the new pricing deal. Major questions about the finer points of the plan also linger, such as how many drugs would be on the negotiating table — and which.